About PLEXISION INC
Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. The company's state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.
Developing cellular biomarkers for personalized diagnosis and drug developmentPerforming custom R&D projects in all phases of drug developmentOffering blood tests to predict transplant rejection, viral infections, immune deficiency, and immuno-oncology responses
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PLEXISION INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.